Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway.

  • Authors : Lee J; Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Hong SW

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Feb; Vol. 39 (1), pp. 98-108. Date of Electronic Publication: 2024 Jan 03.Publisher: Korean Endocrine Society Country of Publication: Korea (South) NLM ID: 101554139 Publication Model: Print-Electronic

تفاصيل العنوان

×
Academic Journal

Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway.

  • Authors : Lee J; Institute of Medical Research, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; Hong SW

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/chemically induced ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy

  • Source: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2022 Feb; Vol. 37 (1), pp. 74-83. Date of Electronic Publication: 2022 Feb 09.Publisher: Korean Endocrine Society Country of Publication: Korea (South) NLM ID: 101554139 Publication Model: Print-Electronic

تفاصيل العنوان

×
Academic Journal

Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway.

  • Authors : Jin JQ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Han JS

Subjects: PPAR gamma*/PPAR gamma*/PPAR gamma*/agonists ; Pyrimidines*/Pyrimidines*/Pyrimidines*/pharmacology ; Thiazolidinediones*/Thiazolidinediones*/Thiazolidinediones*/pharmacology

  • Source: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2021 Oct; Vol. 36 (5), pp. 1095-1110. Date of Electronic Publication: 2021 Oct 14.Publisher: Korean Endocrine Society Country of Publication: Korea (South) NLM ID: 101554139 Publication Model: Print-Electronic

تفاصيل العنوان

×
  • 1-10 ل  91 نتائج ل ""signaling pathway""